The first patient with small cell lung cancer has been dosed in a trial of peluntamig (PT217) combined with chemotherapy.

Panelists discuss how to identify, monitor, and manage delayed toxicities following ciltacabtagene autoleucel (cilta-cel) chimeric antigen receptor (CAR) T therapy, including prolonged cytopenias, ...

Tyra Biosciences' TYRA-300 shows promise as an FGFR3 inhibitor with fewer side effects, but mixed market reactions spotlight ...

Unlike monoclonal antibodies, bispecific antibodies bind to 2 different antigens simultaneously,[1][1] directing T cells toward cancer cells to exert a cytotoxic killing effect.[1][1] Bispecific ...

Researchers have developed a near-infrared (NIR) fluorescent nanosensor capable of simultaneously detecting and ...

As the medical community monitors the risk of avian influenza outbreaks to humans, health influencers are claiming that black ...

OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced a collaboration with Gustave Roussy, the first European cancer center, to ...

An expert explains that the GAP regimen did not improve overall survival in advanced biliary tract cancer versus the doublet ...

Maria Menounos' husband Keven Undergaro opens up about welcoming daughter Athena at 56, sharing his tips and tricks in an ...

Candel Therapeutics' recent phase 2 results in pancreatic cancer showed promising median survival but led to a 20% stock drop ...

A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides guidance on the use of radiation ...